Skip to main content
Premium Trial:

Request an Annual Quote

Two Blades Licenses Genome Engineering Technology to Monsanto for Plant Applications

NEW YORK (GenomeWeb News) – The Two Blades Foundation said on Monday that it has licensed the TAL Code technology to Monsanto on a non-exclusive basis.

Two Blades has exclusive rights for commercial use of the technology in plants. Improvements made to the technology by Monsanto will be used by the foundation as part of its efforts to support subsistence farming.

The technology, discovered by researchers at Martin-Luther University in Halle, Germany, is based on novel sequence-specific DNA binding proteins that can be designed to recognize almost any sequence of interest. Applied to plants, the technology can accelerate improvements in crop growth and development, Two Blades said.

"Having Monsanto, the worlds' largest seed company, put the TAL Code technology to use in their programs will further ensure its wide use and development," Two Blades' Chief Operating Officer Diana Horvath, said in a statement.

Financial and other terms of the deal were not disclosed.

Two Blades is based in Evanston, Ill., and supports the development of durable disease resistance in crop plants.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.